Global BCG Vaccine Market Professional Survey Report 2020
出 版 商：XYZ Research
出版日期：2019/12/01
頁 數：108頁
文件格式：PDF
價 格：
USD 3,500 (Single-User License)
USD 7,000 (Global-User License)
USD 7,000 (Global-User License)
In this report,global BCG Vaccine Market will reach 342.56 Million USD by the end of 2022 with a CAGR of 4.54%
The global BCG Vaccine market is valued at 274.34 Million USD in 2017 and will reach 342.56 Million USD by the end of 2022, growing at a CAGR of 4.54% during 2017-2022.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guerin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
BCG Vaccine can be divided into two categories—Immune BCG and Therapy BCG type. Therapy BCG type production market share accounted for the highest proportion, with a figure of 94.81% in 2017, Immune BCG type account for 5.19%.
The consumption market share of global BCG Vaccine in Hospital use and Clinic use have been stable year by year, at 74.20% and 25.80% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the BCG Vaccine in the global market tends to be fixed without great changes. Among them, the BCG Vaccine market has the most promising sales prospects in Hospital use.
XYZ research center data shows that North America is the biggest contributor to the BCG Vaccine revenue market, accounted for 34.75% of the total global market with a revenue of 95.32 million USD in 2017, followed by Europe, 32.34% with a revenue of 88.72 million USD.
Market competition is not intense. Sanofi Pasteur is the largest company in the global BCG Vaccine market, accounted for 33.61% of the revenue market share in 2017, followed by Merck and Japan BCG Lab, accounted for 32.71% and 18.34% of the revenue market share in 2017.
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Others
...
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Immune BCG
Therapy BCG
By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
Hospitals
Clinics
Others
By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
The global BCG Vaccine market is valued at 274.34 Million USD in 2017 and will reach 342.56 Million USD by the end of 2022, growing at a CAGR of 4.54% during 2017-2022.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guerin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
BCG Vaccine can be divided into two categories—Immune BCG and Therapy BCG type. Therapy BCG type production market share accounted for the highest proportion, with a figure of 94.81% in 2017, Immune BCG type account for 5.19%.
The consumption market share of global BCG Vaccine in Hospital use and Clinic use have been stable year by year, at 74.20% and 25.80% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the BCG Vaccine in the global market tends to be fixed without great changes. Among them, the BCG Vaccine market has the most promising sales prospects in Hospital use.
XYZ research center data shows that North America is the biggest contributor to the BCG Vaccine revenue market, accounted for 34.75% of the total global market with a revenue of 95.32 million USD in 2017, followed by Europe, 32.34% with a revenue of 88.72 million USD.
Market competition is not intense. Sanofi Pasteur is the largest company in the global BCG Vaccine market, accounted for 33.61% of the revenue market share in 2017, followed by Merck and Japan BCG Lab, accounted for 32.71% and 18.34% of the revenue market share in 2017.
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Others
...
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Immune BCG
Therapy BCG
By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
Hospitals
Clinics
Others
By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global BCG Vaccine Market Professional Survey Report 2020
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 Immune BCG
1.3.2 Therapy BCG
1.4 Application Overview
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Others
1.5 Industrial Chain
1.5.1 BCG Vaccine Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 Immune BCG
2.1.2 Therapy BCG
2.2 The Overall Market Performance(Value)
2.2.1 Immune BCG
2.2.2 Therapy BCG
3 Global BCG Vaccine Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Hospitals
3.3 Clinics
3.4 Others
4 Competitive Analysis
4.1 Merck
4.1.1 Merck Profiles
4.1.2 Merck Product Information
4.1.3 Merck BCG Vaccine Business Performance
4.1.4 SWOT Analysis
4.2 Sanofi Pasteur
4.2.1 Sanofi Pasteur Profiles
4.2.2 Sanofi Pasteur Product Information
4.2.3 Sanofi Pasteur BCG Vaccine Business Performance
4.2.4 SWOT Analysis
4.3 Japan BCG Lab
4.3.1 Japan BCG Lab Profiles
4.3.2 Japan BCG Lab Product Information
4.3.3 Japan BCG Lab BCG Vaccine Business Performance
4.3.4 SWOT Analysis
4.4 China National Biotec
4.4.1 China National Biotec Profiles
4.4.2 China National Biotec Product Information
4.4.3 China National Biotec BCG Vaccine Business Performance
4.4.4 SWOT Analysis
4.5 Serum Institute of India
4.5.1 Serum Institute of India Profiles
4.5.2 Serum Institute of India Product Information
4.5.3 Serum Institute of India BCG Vaccine Business Performance
4.5.4 SWOT Analysis
4.6 Intervax
4.6.1 Intervax Profiles
4.6.2 Intervax Product Information
4.6.3 Intervax BCG Vaccine Business Performance
4.6.4 SWOT Analysis
4.7 GSBPL
4.7.1 GSBPL Profiles
4.7.2 GSBPL Product Information
4.7.3 GSBPL BCG Vaccine Business Performance
4.7.4 SWOT Analysis
4.8 Others
4.8.1 Others Profiles
4.8.2 Others Product Information
4.8.3 Others BCG Vaccine Business Performance
4.8.4 SWOT Analysis
5 Competitive Lanscape
5.1 Global BCG Vaccine Capacity (K Units) and Market Share of Manufacturers (2014-2020)
5.2 Global BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
5.3 Global BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
5.4 Global BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
5.5 Global BCG Vaccine Gross Margin of Manufacturers (2014-2020)
5.6 Market Concentration
6 Regional Market Analysis
6.1 China Market Performance for Manufacturers
6.1.1 China BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.1.2 China BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.1.3 China BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 China BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.2.2 USA BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.2.3 USA BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 USA BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.3.2 Europe BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.3.3 Europe BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 Europe BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.4.2 Japan BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.4.3 Japan BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 Japan BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.5.2 Korea BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.5.3 Korea BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.5.4 Korea BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.6.2 India BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.6.3 India BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.6.4 India BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.7.2 Southeast Asia BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.7.3 Southeast Asia BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.7.4 Southeast Asia BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.8.2 South America BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.8.3 South America BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.8.4 South America BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.8.5 Market Concentration
7 Global BCG Vaccine Market Assessment by Regions
7.1 Global BCG Vaccine Capacity (K Units) and Market Share by Regions (2014-2020)
7.2 Global BCG Vaccine Sales (K Units) and Market Share by Regions (2014-2020)
7.3 Global BCG Vaccine Revenue (M USD) and Market Share by Regions (2014-2020)
7.4 Global BCG Vaccine Price (USD/Unit) by Regions (2014-2020)
7.5 Global BCG Vaccine Gross Margin by Regions (2014-2020)
8 Capacity Analysis of Different Regions
8.1 Global BCG Vaccine Capacity and Growth Rate (2014-2020)
8.2 China BCG Vaccine Capacity and Growth Rate (2014-2020)
8.3 USA BCG Vaccine Capacity and Growth Rate (2014-2020)
8.4 Europe BCG Vaccine Capacity and Growth Rate (2014-2020)
8.5 Japan BCG Vaccine Capacity and Growth Rate (2014-2020)
8.6 Korea BCG Vaccine Capacity and Growth Rate (2014-2020)
8.7 India BCG Vaccine Capacity and Growth Rate (2014-2020)
8.8 Southeast Asia BCG Vaccine Capacity and Growth Rate (2014-2020)
8.9 South America BCG Vaccine Capacity and Growth Rate (2014-2020)
9 Technology and Cost Analysis
9.1 Technology
9.2 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution of Global BCG Vaccine Major Manufacturers
11 Global BCG Vaccine Market Forecast by Regions
11.1 Global BCG Vaccine Market Forecast (2021-2026)
11.1.1 Global BCG Vaccine Capacity Forecast by Regions (2021-2026)
11.1.2 Global BCG Vaccine Sales Forecast by Regions (2021-2026)
11.1.2 Global BCG Vaccine Revenue Forecast by Regions (2021-2026)
11.2 China BCG Vaccine Market Forecast (2021-2026)
11.3 USA BCG Vaccine Market Forecast (2021-2026)
11.4 Europe BCG Vaccine Market Forecast (2021-2026)
11.5 Japan BCG Vaccine Market Forecast (2021-2026)
11.6 Korea BCG Vaccine Market Forecast (2021-2026)
11.7 India BCG Vaccine Market Forecast (2021-2026)
11.8 Southeast Asia BCG Vaccine Market Forecast (2021-2026)
11.9 South America BCG Vaccine Market Forecast (2021-2026)
12 Global BCG Vaccine Market Forecast by Types (2021-2026)
12.1 Overall Market Performance (Sales, Revenue)
12.2 Immune BCG
12.3 Therapy BCG
13 Global BCG Vaccine Market Forecast by Application (2021-2026)
13.1 Overall Market Performance (Sales and Growth Rate)
13.2 Hospitals
13.3 Clinics
13.4 Others
14 Global Price (USD/Unit) and Gross Profit Forecast
14.1 Global BCG Vaccine Average Price Forecast (2021-2026)
14.2 Global BCG Vaccine Gross Profit Forecast (2021-2026)
15 Conclusion
Global BCG Vaccine Market Professional Survey Report 2020
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 Immune BCG
1.3.2 Therapy BCG
1.4 Application Overview
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Others
1.5 Industrial Chain
1.5.1 BCG Vaccine Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 Immune BCG
2.1.2 Therapy BCG
2.2 The Overall Market Performance(Value)
2.2.1 Immune BCG
2.2.2 Therapy BCG
3 Global BCG Vaccine Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Hospitals
3.3 Clinics
3.4 Others
4 Competitive Analysis
4.1 Merck
4.1.1 Merck Profiles
4.1.2 Merck Product Information
4.1.3 Merck BCG Vaccine Business Performance
4.1.4 SWOT Analysis
4.2 Sanofi Pasteur
4.2.1 Sanofi Pasteur Profiles
4.2.2 Sanofi Pasteur Product Information
4.2.3 Sanofi Pasteur BCG Vaccine Business Performance
4.2.4 SWOT Analysis
4.3 Japan BCG Lab
4.3.1 Japan BCG Lab Profiles
4.3.2 Japan BCG Lab Product Information
4.3.3 Japan BCG Lab BCG Vaccine Business Performance
4.3.4 SWOT Analysis
4.4 China National Biotec
4.4.1 China National Biotec Profiles
4.4.2 China National Biotec Product Information
4.4.3 China National Biotec BCG Vaccine Business Performance
4.4.4 SWOT Analysis
4.5 Serum Institute of India
4.5.1 Serum Institute of India Profiles
4.5.2 Serum Institute of India Product Information
4.5.3 Serum Institute of India BCG Vaccine Business Performance
4.5.4 SWOT Analysis
4.6 Intervax
4.6.1 Intervax Profiles
4.6.2 Intervax Product Information
4.6.3 Intervax BCG Vaccine Business Performance
4.6.4 SWOT Analysis
4.7 GSBPL
4.7.1 GSBPL Profiles
4.7.2 GSBPL Product Information
4.7.3 GSBPL BCG Vaccine Business Performance
4.7.4 SWOT Analysis
4.8 Others
4.8.1 Others Profiles
4.8.2 Others Product Information
4.8.3 Others BCG Vaccine Business Performance
4.8.4 SWOT Analysis
5 Competitive Lanscape
5.1 Global BCG Vaccine Capacity (K Units) and Market Share of Manufacturers (2014-2020)
5.2 Global BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
5.3 Global BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
5.4 Global BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
5.5 Global BCG Vaccine Gross Margin of Manufacturers (2014-2020)
5.6 Market Concentration
6 Regional Market Analysis
6.1 China Market Performance for Manufacturers
6.1.1 China BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.1.2 China BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.1.3 China BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 China BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.2.2 USA BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.2.3 USA BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 USA BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.3.2 Europe BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.3.3 Europe BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 Europe BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.4.2 Japan BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.4.3 Japan BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 Japan BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.5.2 Korea BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.5.3 Korea BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.5.4 Korea BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.6.2 India BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.6.3 India BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.6.4 India BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.7.2 Southeast Asia BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.7.3 Southeast Asia BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.7.4 Southeast Asia BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America BCG Vaccine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.8.2 South America BCG Vaccine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.8.3 South America BCG Vaccine Price (USD/Unit) of Manufacturers (2014-2020)
6.8.4 South America BCG Vaccine Gross Margin of Manufacturers (2014-2020)
6.8.5 Market Concentration
7 Global BCG Vaccine Market Assessment by Regions
7.1 Global BCG Vaccine Capacity (K Units) and Market Share by Regions (2014-2020)
7.2 Global BCG Vaccine Sales (K Units) and Market Share by Regions (2014-2020)
7.3 Global BCG Vaccine Revenue (M USD) and Market Share by Regions (2014-2020)
7.4 Global BCG Vaccine Price (USD/Unit) by Regions (2014-2020)
7.5 Global BCG Vaccine Gross Margin by Regions (2014-2020)
8 Capacity Analysis of Different Regions
8.1 Global BCG Vaccine Capacity and Growth Rate (2014-2020)
8.2 China BCG Vaccine Capacity and Growth Rate (2014-2020)
8.3 USA BCG Vaccine Capacity and Growth Rate (2014-2020)
8.4 Europe BCG Vaccine Capacity and Growth Rate (2014-2020)
8.5 Japan BCG Vaccine Capacity and Growth Rate (2014-2020)
8.6 Korea BCG Vaccine Capacity and Growth Rate (2014-2020)
8.7 India BCG Vaccine Capacity and Growth Rate (2014-2020)
8.8 Southeast Asia BCG Vaccine Capacity and Growth Rate (2014-2020)
8.9 South America BCG Vaccine Capacity and Growth Rate (2014-2020)
9 Technology and Cost Analysis
9.1 Technology
9.2 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution of Global BCG Vaccine Major Manufacturers
11 Global BCG Vaccine Market Forecast by Regions
11.1 Global BCG Vaccine Market Forecast (2021-2026)
11.1.1 Global BCG Vaccine Capacity Forecast by Regions (2021-2026)
11.1.2 Global BCG Vaccine Sales Forecast by Regions (2021-2026)
11.1.2 Global BCG Vaccine Revenue Forecast by Regions (2021-2026)
11.2 China BCG Vaccine Market Forecast (2021-2026)
11.3 USA BCG Vaccine Market Forecast (2021-2026)
11.4 Europe BCG Vaccine Market Forecast (2021-2026)
11.5 Japan BCG Vaccine Market Forecast (2021-2026)
11.6 Korea BCG Vaccine Market Forecast (2021-2026)
11.7 India BCG Vaccine Market Forecast (2021-2026)
11.8 Southeast Asia BCG Vaccine Market Forecast (2021-2026)
11.9 South America BCG Vaccine Market Forecast (2021-2026)
12 Global BCG Vaccine Market Forecast by Types (2021-2026)
12.1 Overall Market Performance (Sales, Revenue)
12.2 Immune BCG
12.3 Therapy BCG
13 Global BCG Vaccine Market Forecast by Application (2021-2026)
13.1 Overall Market Performance (Sales and Growth Rate)
13.2 Hospitals
13.3 Clinics
13.4 Others
14 Global Price (USD/Unit) and Gross Profit Forecast
14.1 Global BCG Vaccine Average Price Forecast (2021-2026)
14.2 Global BCG Vaccine Gross Profit Forecast (2021-2026)
15 Conclusion
